These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16275986)

  • 1. PRL phosphatases as potential molecular targets in cancer.
    Stephens BJ; Han H; Gokhale V; Von Hoff DD
    Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
    Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
    Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase of regenerating liver: a novel target for cancer therapy.
    Campbell AM; Zhang ZY
    Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting phosphatases of regenerating liver (PRLs) in cancer.
    Wei M; Korotkov KV; Blackburn JS
    Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.
    Guo K; Tang JP; Tan CP; Wang H; Zeng Q
    Cancer Biol Ther; 2008 May; 7(5):750-7. PubMed ID: 18364570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.
    Peng L; Xing X; Li W; Qu L; Meng L; Lian S; Jiang B; Wu J; Shou C
    Mol Cancer; 2009 Nov; 8():110. PubMed ID: 19930715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
    Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
    Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-3 phosphatase and cancer metastasis.
    Al-Aidaroos AQ; Zeng Q
    J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia.
    Zhou J; Chong PS; Lu X; Cheong LL; Bi C; Liu SC; Zhou Y; Tan TZ; Yang H; Chung TH; Zeng Q; Chng WJ
    Exp Hematol; 2014 Dec; 42(12):1041-52.e1-2. PubMed ID: 25139404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells.
    Stephens B; Han H; Hostetter G; Demeure MJ; Von Hoff DD
    Mol Cancer Ther; 2008 Jan; 7(1):202-10. PubMed ID: 18187808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
    Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
    J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatase of regenerating liver maintains cellular magnesium homeostasis.
    Yoshida A; Funato Y; Miki H
    Biochem J; 2018 Mar; 475(6):1129-1139. PubMed ID: 29487165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.